Epidemiology of childhood peanut allergy

Ashley A Dyer1, Victoria Rivkina, Dhivya Perumal

  • 1Northwestern University, Feinberg School of Medicine, Center for Community Health, Chicago, IL, USA.

Insights

Childhood peanut allergy is common, affecting nearly a quarter of all food allergies. This allergy often causes severe reactions and is less likely to be outgrown, with persistent socioeconomic disparities in diagnosis.

Area of Science:

  • Pediatric Allergy and Immunology
  • Epidemiology
  • Public Health

Background:

  • Peanut allergy is a prevalent food allergy in children.
  • Limited comprehensive epidemiological data exists for pediatric peanut allergy in the U.S.
  • Understanding prevalence, diagnosis, and reaction patterns is crucial.

Purpose of the Study:

  • To characterize the epidemiology of peanut allergy in a representative U.S. pediatric population.
  • To examine trends in diagnosis and reaction history.
  • To identify demographic and socioeconomic factors associated with peanut allergy.

Main Methods:

  • A randomized, cross-sectional survey of 38,480 U.S. households with children (June 2009-February 2010).
  • Data collected on demographics, allergic symptoms, and food allergy diagnosis methods.
  • Statistical models used to assess associations with peanut allergy.

Main Results:

  • Peanut allergy was reported in 24.8% of children with food allergy (754/3218).
  • Higher prevalence observed in 6-10 year olds, white children, and households with $50k-$99k income.
  • Peanut allergy reactions were more severe (53.7%) than other food allergies (41.0%); tolerance was less likely reported.

Conclusions:

  • Childhood peanut allergy is a significant public health issue, representing a substantial portion of pediatric food allergies.
  • It is associated with more severe reactions and lower rates of outgrowing the allergy.
  • Despite high physician diagnosis rates (76%), socioeconomic disparities in diagnosis persist.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
886
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
237
Allergic Reactions02:06

Allergic Reactions

Overview
34.4K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
371
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
513